BRD3OS and skin squamous cell carcinoma: The analysis showed that there was no strong (more than two particles in cell) (+++) expression of BRD3OS (LINC00094) in normal skin samples (0% of cases), and the strong (+++) positive expression was noted significantly more in premalignant lesions (AK and cSCCIS) (42% of cases), invasive primary non-metastatic cSCCs (55%), primary metastatic cSCCs (70%), and cSCC metastases (75%) than in normal skin (0%) (Figure 2G).